As STERIS plc (NYSE: STE) projects a positive outlook for fiscal 2025, bolstered by its strong performance in the healthcare segment and strategic initiatives, the company's financial metrics and market sentiment provide additional context for investors. According to real-time data from InvestingPro, STERIS has a market capitalization of $22.34 billion and trades at a forward P/E ratio of 38.93, reflecting a premium valuation in the market. The company's revenue growth over the last twelve months as of Q3 2024 stands at 13.04%, signaling robust business expansion.